INDP Indaptus Therapeutics Inc
Company Analysis
Latest News
🔴 Indaptus Therapeutics is trading 11% down as the reason remains unclear
Indaptus Therapeutics is trading 10.88% down at $2.54, with no clear reason identified for the September 30 decline. - Shares fell 13.37% on September 29 and...
🟢 Indaptus Therapeutics is trading 7% up in pre-market with no clear catalyst identified
Indaptus Therapeutics is trading at $3.05, up 7.02%, with no clear company-specific news explaining the September 30 pre-market gain. - The latest identified...
🟢 Indaptus Therapeutics is trading 8.07% up in after-hours trading with no clear catalyst identified
Indaptus Therapeutics is trading 8.07% up at $3.08 in after-hours, with no clear company-specific catalyst identified. - The September 29 regular-session close...
🔴 Indaptus Therapeutics is trading 10.64% down — as no clear catalyst was identified
Indaptus Therapeutics is trading 10.64% lower at $2.94; the specific reason for the September 29, 2026 decline remains unclear. - No clear company-specific...
🔴 Indaptus Therapeutics is trading 6.7% down with no clear company-specific catalyst
Indaptus Therapeutics is trading 6.7% lower at $3.07; no clear company-specific announcement explaining the September 29 move was identified. - Recent...
🟢 Indaptus Therapeutics is trading 9.72% up in after-hours trading with no identified catalyst
Indaptus Therapeutics is trading at $3.61, up 9.72% versus the regular-session close of $3.29; the cause of the after-hours rise is unclear. - No new...
🔴 Indaptus Therapeutics is trading 10.5% down — no new company-specific catalyst identified
Indaptus Therapeutics is trading 10.52% lower at $3.44, with no new company-specific announcement identified to explain the September 28, 2026 decline. - The...
🔴 Indaptus Therapeutics is trading 11% down today with no clear catalyst
Indaptus Therapeutics is trading at $3.56, a -11.00% move, with no clear company-specific announcement explaining the September 25, 2026 decline. - The...
🔴 Indaptus Therapeutics is trading 6.25% down today with no clear company-specific catalyst
Indaptus Therapeutics is trading 6.25% down at $3.75, with no clear company-specific catalyst identified for September 25, 2026. - The previously announced...
🟢 Indaptus Therapeutics is trading 6.63% up today; catalyst remains unclear
Indaptus Therapeutics is trading 6.63% higher at $4.02, with no company-specific announcement or regulatory catalyst identified for September 24, 2026. - The...
🟢 Indaptus Therapeutics is trading 5.84% up in pre-market as XBI gains 2.61%
Indaptus Therapeutics is trading 5.84% higher at $3.99 in pre-market, primarily supported by stronger biotech sentiment, with XBI up 2.61%. - Shares closed at...
🔴 Indaptus Therapeutics is trading 10.64% down today amid stock-specific volatility and weaker U.S. indexes
Indaptus Therapeutics is trading at $3.57, down 10.64%, amid continued stock-specific volatility and weaker major U.S. indexes. - No new company-specific...
🔴 Indaptus Therapeutics is trading 6.77% down today with no new company-specific catalyst identified
Indaptus Therapeutics is trading 6.77% down at $3.72 amid stock-specific volatility, with no new company-specific announcement or direct catalyst identified...
🟢 Indaptus Therapeutics is trading 6.52% up in pre-market amid broader biotech strength
Indaptus Therapeutics is trading 6.52% higher at $4.25, after closing September 22, 2026 at $3.99, with broader biotechnology-sector strength supporting...
🟢 Indaptus Therapeutics is trading 10.19% up today — no clear catalyst identified
Indaptus Therapeutics is trading at $3.40, up 10.19%, with the rally’s precise reason unclear. - It rebounded from the September 21, 2026 close of $3.09 after...
🔴 Indaptus Therapeutics is trading 10% down today after opening-market selling
Indaptus Therapeutics is trading 10% down at $3.19 after opening-market selling, with no clear company-specific announcement identified for September 21,...
🔴 Indaptus Therapeutics is trading 5.41% down today with no clear company-specific announcement
Indaptus Therapeutics is trading 5.41% down at $3.36, with no clear company-specific announcement explaining the September 21 decline. - It follows a close of...
🟢 Indaptus Therapeutics is trading 5.6% up in pre-market with no clear company-specific catalyst
Indaptus Therapeutics is trading at $3.75, up 5.63%, with no fresh company-specific announcement identified to explain the move. • The stock closed at $3.55...
🟢 Indaptus Therapeutics is trading 5% up today in after-hours trading with no clear company-specific catalyst
Indaptus Therapeutics is trading 5.07% up now at $3.73 after its September 18, 2026, close at $3.55, down 9.67%; no fresh company-specific announcement...
🔴 Indaptus Therapeutics is trading 5.1% down today, reversing part of September 17 advance
Indaptus Therapeutics is trading 5.1% down at $3.73, with no fresh company-specific announcement clearly explaining the September 18 decline. - The move...